Implementation of an ADME enabling selection and visualization tool for drug discovery
- PMID: 15067690
- DOI: 10.1002/jps.20020
Implementation of an ADME enabling selection and visualization tool for drug discovery
Abstract
The pharmaceutical industry has large investments in compound library enrichment, high throughput biological screening, and biopharmaceutical (ADME) screening. As the number of compounds submitted for in vitro ADME screens increases, data analysis, interpretation, and reporting will become rate limiting in providing ADME-structure-activity relationship information to guide the synthetic strategy for chemical series. To meet these challenges, a software tool was developed and implemented that enables scientists to explore in vitro and in silico ADME and chemistry data in a multidimensional framework. The present work integrates physicochemical and ADME data, encompassing results for Caco-2 permeability, human liver microsomal half-life, rat liver microsomal half-life, kinetic solubility, measured log P, rule of 5 descriptors (molecular weight, hydrogen bond acceptors, hydrogen bond donors, calculated log P), polar surface area, chemical stability, and CYP450 3A4 inhibition. To facilitate interpretation of this data, a semicustomized software solution using Spotfire was designed that allows for multidimensional data analysis and visualization. The solution also enables simultaneous viewing and export of chemical structures with the corresponding ADME properties, enabling a more facile analysis of ADME-structure-activity relationship. In vitro and in silico ADME data were generated for 358 compounds from a series of human immunodeficiency virus protease inhibitors, resulting in a data set of 5370 experimental values which were subsequently analyzed and visualized using the customized Spotfire application. Implementation of this analysis and visualization tool has accelerated the selection of molecules for further development based on optimum ADME characteristics, and provided medicinal chemistry with specific, data driven structural recommendations for improvements in the ADME profile.
Copyright 2004 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 93: 1131-1141, 2004
Similar articles
-
Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.J Pharm Sci. 2010 Apr;99(4):2135-52. doi: 10.1002/jps.21948. J Pharm Sci. 2010. PMID: 19780144
-
In silico pKa prediction and ADME profiling.Chem Biodivers. 2009 Nov;6(11):1812-21. doi: 10.1002/cbdv.200900153. Chem Biodivers. 2009. PMID: 19937818
-
Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery.Int J Pharm. 2004 Jan 9;269(1):241-9. doi: 10.1016/j.ijpharm.2003.09.006. Int J Pharm. 2004. PMID: 14698595
-
Applications of high-throughput ADME in drug discovery.Curr Opin Chem Biol. 2004 Jun;8(3):339-45. doi: 10.1016/j.cbpa.2004.04.015. Curr Opin Chem Biol. 2004. PMID: 15183334 Review.
-
Drug-like property concepts in pharmaceutical design.Curr Pharm Des. 2009;15(19):2184-94. doi: 10.2174/138161209788682479. Curr Pharm Des. 2009. PMID: 19601822 Review.
Cited by
-
Efficacy of Tilorone Dihydrochloride against Ebola Virus Infection.Antimicrob Agents Chemother. 2018 Jan 25;62(2):e01711-17. doi: 10.1128/AAC.01711-17. Print 2018 Feb. Antimicrob Agents Chemother. 2018. PMID: 29133569 Free PMC article.
-
Use of cell viability assay data improves the prediction accuracy of conventional quantitative structure-activity relationship models of animal carcinogenicity.Environ Health Perspect. 2008 Apr;116(4):506-13. doi: 10.1289/ehp.10573. Environ Health Perspect. 2008. PMID: 18414635 Free PMC article.
-
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.J Chem Inf Model. 2015 Jun 22;55(6):1231-45. doi: 10.1021/acs.jcim.5b00143. Epub 2015 Jun 3. J Chem Inf Model. 2015. PMID: 25994950 Free PMC article.
-
Gengnianchun formula ameliorates insulin resistance-induced diminished ovarian reserve via the estrogen signaling pathway: evidence from network pharmacology and experimental validation.J Ovarian Res. 2025 Mar 11;18(1):51. doi: 10.1186/s13048-025-01632-3. J Ovarian Res. 2025. PMID: 40069864 Free PMC article.
-
Discovery of Dual Targeting GSK-3β/HIV-1 Reverse Transcriptase Inhibitors as Neuroprotective Antiviral Agents.ACS Chem Neurosci. 2025 Jan 1;16(1):77-84. doi: 10.1021/acschemneuro.4c00725. Epub 2024 Dec 11. ACS Chem Neurosci. 2025. PMID: 39663760
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials